Peroxisome proliferator-activated receptor gamma agonists for the prevention of adverse events following percutaneous coronary revascularization-results of the PPAR study

Deepak Bhatt, Derek Chew, Cindy Grines, Debabrata Mukherjee, Massoud Leesar, Ian Gilchrist, John Corbelli, James Blankenship, Avichai Eres, Steven Steinhubl, Walter Tan, Jon Resar, Amjad AlMahameed, Ahmed Abdel-Latif, H Tang, Danielle Brennan, Ellen McErlean, Stanley Hazen, Eric Topol

    Research output: Contribution to journalArticle

    29 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)137-143
    Number of pages7
    JournalAmerican Heart Journal
    Volume154
    Issue number1
    Publication statusPublished - 2007

    Cite this

    Bhatt, D., Chew, D., Grines, C., Mukherjee, D., Leesar, M., Gilchrist, I., Corbelli, J., Blankenship, J., Eres, A., Steinhubl, S., Tan, W., Resar, J., AlMahameed, A., Abdel-Latif, A., Tang, H., Brennan, D., McErlean, E., Hazen, S., & Topol, E. (2007). Peroxisome proliferator-activated receptor gamma agonists for the prevention of adverse events following percutaneous coronary revascularization-results of the PPAR study. American Heart Journal, 154(1), 137-143.